[1]
|
Dekker, E., Tanis, P.J., Vleugels, J., et al. (2019) Colorectal Cancer. The Lancet, 394, 1467-1480.
https://doi.org/10.1016/S0140-6736(19)32319-0
|
[2]
|
李为民, 刘丹, 卢铀. 肺癌诊治水平的进展与提高[J]. 四川大学学报(医学版), 2014, 45(2): 289-292.
|
[3]
|
朱成章, 张维胜, 杜斌斌, 等. 肠道菌群失调与罹患结直肠癌风险的研究进展[J]. 中华结直肠疾病电子杂志, 2021, 10(1): 95-98.
|
[4]
|
卫生部医政司, 卫生部办公厅. 结直肠癌诊疗规范(2010年版) [J]. 中华外科杂志, 2011(2): 97-104.
|
[5]
|
屠世良, 叶再元, 邓高里, 等. 结直肠癌淋巴结转移的规律及其影响因素[J]. 中华胃肠外科杂志, 2007(3): 257-260.
|
[6]
|
李季, 沈艳, 姜研. CT仿真结肠镜联合肿瘤标志物检测在结直肠癌中的诊断价值[J]. 医学综述, 2021, 27(5): 1032-1036.
|
[7]
|
游金辉, 黄霓. 结直肠癌PET/CT显像的应用与研究进展[J]. 川北医学院学报, 2019, 34(1): 155-159.
|
[8]
|
豆晓锋, 邵佳栋, 李晶. PET/CT显像在结直肠癌术后复发及转移诊断中的临床应用价值[J]. 影像研究与医学应用, 2018, 2(22): 6-7.
|
[9]
|
李宣海. 肿瘤标志物的检测与临床[M]. 北京: 人民卫生出版社, 1997.
|
[10]
|
崔秀玉, 李秀平, 于谨铭, 等. 血清CA199, CA242, CEA联合检测对胰腺癌的临床意义[J]. 医学检验与临床, 2010, 21(5): 14-15, 13.
|
[11]
|
孙巍, 王琼, 刘娟, 等. 血清肿瘤标志在结直肠癌诊断中的应用[J]. 中华检验医学杂志, 2000(1): 10-12.
|
[12]
|
边鹏, 刘瑞红, 张喜雨, 等. 基于病案数据的结直肠癌远处转移影响因素分析[J]. 中国病案, 2021, 22(3): 86-90.
|
[13]
|
史益凡, 林春燕, 鲍传庆, 等. 中西医结合快速康复外科理念在腹腔镜结直肠癌手术中的应用[J]. 中国中西医结合外科杂志, 2018, 24(6): 766-769.
|
[14]
|
练磊, 兰平. 国家卫健委中国结直肠癌诊疗规范解读(2020版)——外科部分[J]. 临床外科杂志, 2021, 29(1): 10-12.
|
[15]
|
Andreola, S., Leo, E., Belli, F., et al. (1997) Distal Intramural Spread in Adenocarcinoma of the Lower Third of the Rectum Treated with Total Resection and Coloanal Anastomosis. Diseases of the Colon & Rectum, 40, 25-29.
https://doi.org/10.1007/BF02055677
|
[16]
|
Wolmark, N. and Fisher, B. (1986) An Analysis of Survival and Treatment Failure Following Abdominoperineal and Sphincter-Saving Resection in Dukes’ B and C Rectal Carcinoma. A Report of the NSABP Clinical Trials. National Surgical Adjuvant Breast and Bowel Project. Annals of Surgery, 204, 480-489.
https://doi.org/10.1097/00000658-198610000-00016
|
[17]
|
Kim, Y., Kim, N., Min, B., et al. (2009) Factors Associated with Anastomotic Recurrence after Total Mesorectal Excision in Rectal Cancer Patients. Journal of Surgical Oncology, 99, 58-64. https://doi.org/10.1002/jso.21166
|
[18]
|
封益飞, 唐俊伟, 王勇, 等. 肠道支架置入联合择期手术与急诊手术在梗阻性结直肠癌治疗中的对比分析[J]. 腹腔镜外科杂志, 2021, 26(3): 218-222.
|
[19]
|
Borschitz, T., Wachtlin, D., Hler, M., et al. (2008) Neoadjuvant Chemoradiation and Local Excision for T2-3 Rectal Cancer. Annals of Surgical Oncology, 15, 712-720. https://doi.org/10.1245/s10434-007-9732-x
|
[20]
|
Read, T.E., Andujar, J.E., Caushaj, P.F., et al. (2004) Neoadjuvant Therapy for Rectal Cancer: Histologic Response of the Primary Tumor Predicts Nodal Status. Diseases of the Colon & Rectum, 47, 825-831.
https://doi.org/10.1007/s10350-004-0535-x
|
[21]
|
Petrelli, F., Trevisan, F., Cabiddu, M., et al. (2019) Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-Analysis of Treatment Outcomes. Annals of Surgery, 271, 1.
https://doi.org/10.1097/SLA.0000000000003471
|
[22]
|
肖刘牛, 朱丽, 陈颖铭, 等. II期结直肠癌术后化疗临床预后危险因素的Meta分析[J]. 循证医学, 2019, 19(3): 167-177.
|
[23]
|
樊嘉, 顾晋, 秦新裕, 等. 中国结直肠癌肝转移诊断和综合治疗指南(2020) [J]. 中国临床医学, 2021, 28(1): 129-144.
|
[24]
|
Andre, T., Boni, C., Navarro, M., et al. (2009) Improved Overall Survival with Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial. Journal of Clinical Oncology, 27, 3109-3116.
https://doi.org/10.1200/JCO.2008.20.6771
|
[25]
|
Tveit, K.M., et al. (1997) Combined Modality Treatment Including Intraoperative Radiotherapy in Locally Advanced and Recurrent Rectal Cancer. Radiotherapy and Oncology, 44, 277-282.
https://doi.org/10.1016/S0167-8140(97)00070-4
|
[26]
|
Yu, T.K., Bhosale, P.R., Crane, C.H., et al. (2008) Patterns of Locoregional Recurrence after Surgery and Radiotherapy or Chemoradiation for Rectal Cancer. International Journal of Radiation Oncology Biology Physics, 71, 1175-1180.
https://doi.org/10.1016/j.ijrobp.2007.11.018
|
[27]
|
Stillwell, A.P., Buettner, P.G. and Ho, Y.H. (2010) Meta-Analysis of Survival of Patients with Stage IV Colorectal Cancer Managed with Surgical Resection versus Chemotherapy Alone. World Journal of Surgery, 34, 797-807.
https://doi.org/10.1007/s00268-009-0366-y
|
[28]
|
van Rooijen, K.L., Shi, Q., Goey, K., et al. (2018) Prognostic Value of Primary Tumour Resection in Synchronous Metastatic Colorectal Cancer: Individual Patient Data Analysis of First-Line Randomised Trials from the ARCAD Database. European Journal of Cancer, 91, 99-106. https://doi.org/10.1016/j.ejca.2017.12.014
|
[29]
|
王磊, 蔡建, 秦启元. 结直肠癌腹膜转移治疗的争议与思考[J]. 中华外科杂志, 2018, 56(8): 569-572.
|
[30]
|
崔书中, 王佳泓, 张相良. 肿瘤细胞减灭术联合腹腔热灌注化疗治疗结直肠癌腹膜转移癌[J]. 中国肿瘤临床, 2012, 39(22): 1691-1695.
|
[31]
|
Park, E.J., Baik, S.H., Hur, H., et al. (2017) Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Cancer with Peritoneal Carcinomatosis. Medicine, 96, e6632.
https://doi.org/10.1097/MD.0000000000006632
|
[32]
|
Portilla, A.G., Cendoya, I., Tejada, I., et al. (2005) Peritoneal Carcinomatosis of Colorectal Origin. Current Treatment. Review and Update. Revista Espanola de Enfermedades Digestivas, 97, 716.
https://doi.org/10.4321/S1130-01082005001000005
|
[33]
|
赵志勋, 裴炜, 熊斌, 等. 结直肠癌腹膜转移诊治中国专家意见(2017) [J]. 中华结直肠疾病电子杂志, 2017, 6(5): 360-366.
|
[34]
|
Roemer-Becuwe, C., Krakowski, I. and Conroy, T. (2003) Bisphosphonates, Pain and Quality of Life in Metastatic Breast Cancer Patients: A Literature Review. Bulletin du Cancer, 90, 1097-1105.
|
[35]
|
马晨曦, 关旭, 王锡山. 结直肠癌骨转移的研究现状及治疗[J]. 中华结直肠疾病电子杂志, 2020, 9(6): 605-609.
|
[36]
|
赵亮, 苏佳灿. 结直肠癌骨转移研究进展[J]. 中国骨与关节杂志, 2012, 1(2): 182-184.
|
[37]
|
Sorich, M.J., Wiese, M.D., Rowland, A., et al. (2015) Extended RAS Mutations and Anti-EGFR Monoclonal Antibody Survival Benefit in Metastatic Colorectal Cancer: A Meta-Analysis of Randomized, Controlled Trials. Annals of Oncology Official Journal of the European Society for Medical Oncology, 26, 13-21.
https://doi.org/10.1093/annonc/mdu378
|
[38]
|
高静, 孙志伟, 李艳艳, 等. 中国结直肠癌患者966例中KRAS和BRAF基因突变分析[J]. 中华病理学杂志, 2012(9): 579-583.
|
[39]
|
陈海霞, 何亚楠, 王维娜, 等. 结直肠癌组织中KRAS和BRAF基因突变与临床病理特征及预后的关系[J]. 现代肿瘤医学, 2021, 29(4): 626-631.
|
[40]
|
潘思琼, 陆奉科, 李山. 错配修复蛋白MLH1、MSH2、PMS2、MSH6及p53在结直肠癌中的表达及意义[J]. 海南医学, 2021, 32(1): 4-7.
|
[41]
|
黎相照, 刘焕娇, 梁敏仪, 等. 微卫星不稳定性类型及临床病理特征: 基于1394例结直肠癌患者的标本检测[J]. 南方医科大学学报, 2020, 40(11): 1645-1650.
|
[42]
|
刘荫华, 姚宏伟, 周斌, 等. 美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J]. 中国实用外科杂志, 2017(1): 6-9.
|
[43]
|
韩慧敏, 王鹏, 朱冰, 等. 脉管瘤栓在II期结直肠癌中的临床价值研究[J]. 实用肿瘤杂志, 2021, 36(1): 43-46.
|
[44]
|
Kishiki, T., Lapin, B., Matsuoka, H., et al. (2018) Optimal Surveillance Protocols after Curative Resection in Patients with Stage IV Colorectal Cancer: A Multicenter Retrospective Study. Diseases of the Colon & Rectum, 61, 51-57.
https://doi.org/10.1097/DCR.0000000000000950
|
[45]
|
钟玲, 郅程. 阳性淋巴结对数比对Ⅲ期结直肠癌预后的预测价值[J]. 消化肿瘤杂志(电子版), 2020, 12(4): 256-260.
|